• Kai

NEW #Alzheimer’s Drug Controversy Continues ‣

In four papers, #researchers and journalists take on aducanumab's controversial #FDAapproval


Their mission? Analyze what went wrong


bit.ly/3CeUMHq



7 views0 comments

Recent Posts

See All